GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Celltrion Pharm 068760.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

39,400

-0.51%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩536.40bn

FY2016FY2025

Net income

₩38.75bn

FY2016FY2025

Free cash flow

₩68.51bn

FY2016FY2025

Shareholders' equity

₩435.96bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩536.40bn₩477.84bn₩388.79bn₩386.04bn₩398.74bn₩233.57bn₩173.51bn₩146.88bn₩135.86bn₩104.81bn
Research and development₩19.11bn₩13.04bn₩12.71bn₩8.00bn₩6.37bn₩4.61bn₩2.16bn₩1.92bn₩1.03bn₩1.20bn
Operating income₩56.09bn₩37.22bn₩33.40bn₩38.17bn₩47.80bn₩23.63bn₩13.55bn−₩332.9m₩8.67bn₩7.27bn
Net income₩38.75bn₩21.97bn₩21.26bn₩25.96bn₩34.58bn₩20.94bn₩8.60bn−₩9.39bn₩2.71bn₩2.92bn
Diluted earnings per share874.86505.39489.01596.73876.55557.20228.91-262.6686.3777.97

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩759.44bn₩669.46bn₩641.64bn₩599.72bn₩637.88bn₩548.07bn₩470.98bn₩452.44bn₩470.27bn₩510.02bn
Cash and short-term investments—₩63.48bn₩32.21bn₩44.09bn₩88.16bn₩29.75bn₩13.33bn₩9.12bn₩5.95bn₩10.51bn
Total liabilities₩323.48bn₩272.54bn₩264.98bn₩242.94bn₩305.92bn₩247.51bn₩190.95bn₩182.41bn₩176.65bn₩165.37bn
Debt—₩172.17bn₩162.53bn₩160.70bn₩181.03bn₩193.02bn₩161.88bn₩146.98bn₩144.25bn₩138.73bn
Shareholders' equity₩435.96bn₩396.92bn₩376.67bn₩356.79bn₩331.97bn₩300.56bn₩280.03bn₩270.03bn₩293.62bn₩344.65bn
Shares outstanding44m43m43m44m39m38m38m36m31m37m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩86.43bn₩56.59bn₩8.76bn−₩4.05bn₩93.15bn₩36.25bn₩27.85bn₩14.31bn−₩10.16bn−₩15.21bn
Capital spending−₩17.92bn−₩5.98bn−₩6.90bn−₩6.29bn−₩12.50bn−₩41.98bn−₩30.49bn−₩7.21bn−₩1.08bn−₩2.19bn
Free cash flow₩68.51bn₩50.61bn₩1.86bn−₩10.33bn₩80.65bn−₩5.73bn−₩2.63bn₩7.11bn−₩11.24bn−₩17.40bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩153.29bn₩132.12bn₩154.40bn₩138.17bn₩131.30bn₩112.52bn₩135.58bn₩128.13bn
Operating income₩19.31bn₩12.90bn₩13.72bn₩16.11bn₩15.52bn₩10.62bn₩9.55bn₩13.65bn
Net income₩13.72bn₩8.82bn₩8.88bn₩11.46bn₩11.09bn₩7.32bn₩6.21bn₩8.28bn
Diluted earnings per share310.02199.25200.54258.71250.35168.63142.78190.49
Cash from operations−₩2.63bn₩33.83bn₩7.24bn₩23.44bn₩13.37bn₩42.38bn₩56.59bn₩26.79bn
Capital spending—−₩15.41bn−₩2.89bn−₩2.27bn−₩4.91bn−₩7.86bn−₩5.98bn−₩3.81bn
Free cash flow—₩18.42bn₩4.35bn₩21.18bn₩8.46bn₩34.52bn₩50.60bn₩22.97bn
Total assets₩779.18bn₩768.81bn₩759.44bn₩745.80bn₩728.19bn₩675.92bn₩669.46bn₩652.56bn
Cash and short-term investments—————₩91.09bn₩63.48bn₩43.10bn
Debt—————₩167.17bn₩165.64bn₩166.14bn
Shareholders' equity₩449.20bn₩434.82bn₩435.96bn₩426.42bn₩414.34bn₩402.30bn₩396.92bn₩389.98bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating margin10.5%7.8%8.6%9.9%12.0%10.1%———
Net margin7.2%4.6%5.5%6.7%8.7%9.0%———
Return on equity8.9%5.5%5.6%7.3%10.4%7.0%———
Return on assets5.1%3.3%3.3%4.3%5.4%3.8%———
Free cash flow yield———————1.4%-0.7%
Revenue growth12.3%22.9%0.7%-3.2%70.7%34.6%———
Earnings growth76.4%3.3%-18.1%-24.9%65.1%143.4%———
Current ratio1.66x1.58x1.46x1.47x1.27x1.25x———
Debt to equity—0.38x0.37x0.40x0.48x0.59x0.53x——
Equity ratio57.4%59.3%58.7%59.5%52.0%54.8%———
Interest coverage8.41x4.96x4.03x6.14x8.92x5.16x———
R&D as a share of sales3.6%2.7%3.3%2.1%1.6%2.0%———
Buybacks as a share of market value———————-13.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.6%18.1%21.8%
Operating income13.7%18.9%24.3%
Net income14.3%13.1%19.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin9.2%9.2%9.8%8.9%
Net margin6.0%6.0%6.8%5.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings66.3110.0176.199.7120.2352.1140.2-185.6—230.7
Price to sales4.85.19.66.710.431.67.011.910.96.4

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2006
Paid in the year200.00132.562
  • 51-for-50 split · 29 Dec 2025
  • 21-for-20 split · 27 Dec 2024
  • 21-for-20 split · 27 Dec 2023
  • 21-for-20 split · 28 Dec 2022
  • 103-for-100 split · 29 Dec 2021
  • 1.02-for-1 split · 29 Dec 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.